← Leaderboards
Adam Wayne Carrico
University Of California, San Francisco
$20,345,043
Attributed
$43,513,758
Total exposure
17
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.1M · FY2010–25$10M$7.5M$5M$2.5M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$43,513,758 · 17
By mechanism
R01$27,889,101 · 9
UH3$7,684,131 · 2
UG3$6,543,763 · 2
R34$706,972 · 1
P30$354,514 · 1
R03$335,277 · 2
Top collaborators
- Sabina Hirshfield9 shared
- Keith Joseph Horvath9 shared
- Robert H Paul9 shared
- Judith T. Moskowitz8 shared
- Edward W Boyer7 shared
- Christian Grov7 shared
- Mallory O Johnson5 shared
- Monica Gandhi3 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Annesa Flentje$4,561,730
- Scarlett L Gomez$14,448,454
- Anna Maria Napoles$2,444,272
- Matthew A. Spinelli$5,669,060
- Monica Gandhi$27,077,063
Others in their field
Top investigators on “Randomized”
- James Dennis Neaton · Northwestern University$305,243,252
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$292,521,996
- Lawrence Corey · Fred Hutchinson Cancer Center$292,521,996
- Marian Ewell · The Emmes Company, Llc$278,931,253
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$199,647,509
- Beth Baseler · Leidos Biomedical Research, Inc.$194,920,310
Research focus
RandomizedParticipantEvidence BaseViral Load ResultPrimary OutcomeMethamphetaminePersonsEpidemicAffectTransmission ProcessMen Who Have Sex With MenPharmaceutical PreparationsCaringContingency ManagementReportingHiv SeropositivityAntiretroviral TherapyBaseTherapy AdherenceStimulant UsePublic HealthInnovationRandomized Controlled TrialsSecondary Outcome
Grant awards (62)
Optimizing HIV prevention for high-risk methamphetamine-using men who have sex with men$3,096,599
UH3 · FY2025 · AI
Developing a U.S. National Cohort to Improve Virologic Suppression among Stimulant-using Men Living with HIV.$1,828,735
UH3 · FY2025 · DA
Neuroimmune pathways linking chronic psychosocial stress to co-occurring stimulant use and depression in HIV disease: a mechanistic clinical trial$1,201,542
R01 · FY2025 · DA
Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)$1,007,048
R01 · FY2025 · MH · contact PI
Relationship between methamphetamine use, viral reservoir dynamics and clinical progression in treated HIV infection$632,239
R01 · FY2025 · DA
Optimizing HIV prevention for highly vulnerable methamphetamine-using sexual minority men$2,758,797
UH3 · FY2024 · AI
Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)$1,062,625
R01 · FY2024 · MH · contact PI
Developing a U.S. National Cohort to Improve Virologic Suppression among Stimulant-using Men Living with HIV.$970,487
UG3 · FY2024 · DA
Optimizing PrEP adherence in sexual minority men who use stimulants$869,958
R01 · FY2024 · DA · contact PI
Neuroimmune pathways linking chronic psychosocial stress to co-occurring stimulant use and depression in HIV disease: a mechanistic clinical trial$869,488
R01 · FY2024 · DA
Relationship between methamphetamine use, viral reservoir dynamics and clinical progression in treated HIV infection$640,539
R01 · FY2024 · DA
Optimizing HIV prevention for highly vulnerable methamphetamine-using sexual minority men$2,568,889
UG3 · FY2023 · AI
Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)$1,095,679
R01 · FY2023 · MH · contact PI
Developing a U.S. National Cohort to Improve Virologic Suppression among Stimulant-using Men Living with HIV.$1,054,387
UG3 · FY2023 · DA
reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)$990,189
R01 · FY2023 · DA
Optimizing PrEP adherence in sexual minority men who use stimulants$985,906
R01 · FY2023 · DA · contact PI
Relationship between methamphetamine use, viral reservoir dynamics and clinical progression in treated HIV infection$663,951
R01 · FY2023 · DA
Supporting Treatment Adherence for Resilience and Thriving (START): A mHealth intervention to improve ART adherence for HIV-positive stimulant-using men$653,211
R01 · FY2023 · DA · contact PI
Supporting Treatment Adherence for Resilience and Thriving (START): A mHealth intervention to improve ART adherence for HIV-positive stimulant-using men$109,548
R01 · FY2023 · DA · contact PI
Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)$1
R01 · FY2023 · MH · contact PI
Optimizing HIV prevention for highly vulnerable methamphetamine-using sexual minority men$1,950,000
UG3 · FY2022 · AI
Optimizing PrEP adherence in sexual minority men who use stimulants$1,042,929
R01 · FY2022 · DA · contact PI
Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)$1,039,095
R01 · FY2022 · MH · contact PI
reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)$932,305
R01 · FY2022 · DA
MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence among HIV+ Prescription Opioid Users$681,476
R01 · FY2022 · DA
Supporting Treatment Adherence for Resilience and Thriving (START): A mHealth intervention to improve ART adherence for HIV-positive stimulant-using men$625,697
R01 · FY2022 · DA · contact PI
Supporting Treatment Adherence for Resilience and Thriving (START): A mHealth intervention to improve ART adherence for HIV-positive stimulant-using men$64,930
R01 · FY2022 · DA · contact PI
Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)$1,218,576
R01 · FY2021 · MH · contact PI
Optimizing PrEP adherence in sexual minority men who use stimulants$1,042,929
R01 · FY2021 · DA · contact PI
Supporting Treatment Adherence for Resilience and Thriving (START): A mHealth intervention to improve ART adherence for HIV-positive stimulant-using men$799,522
R01 · FY2021 · DA · contact PI
Enhancing Capacity for Mental Health Research and Care in Cambodia$602,382
R01 · FY2021 · MH
MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence among HIV+ Prescription Opioid Users$452,336
R01 · FY2021 · DA
Adaptive intervention strategies to optimize PrEP clinical evaluation and uptake in stimulant-using men$231,275
R34 · FY2021 · DA · contact PI
MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence among HIV+ Prescription Opioid Users$229,594
R01 · FY2021 · DA
Understanding intersectional stigma and substance use through GPS spatial mobility data$66,148
R01 · FY2021 · DA · contact PI
Supporting Treatment Adherence for Resilience and Thriving (START): A mHealth intervention to improve ART adherence for HIV-positive stimulant-using men$64,930
R01 · FY2021 · DA · contact PI
MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence among HIV+ Prescription Opioid Users$23,353
R01 · FY2021 · DA
Optimizing PrEP adherence in sexual minority men who use stimulants$951,699
R01 · FY2020 · DA · contact PI
MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence among HIV+ Prescription Opioid Users$742,489
R01 · FY2020 · DA
Supporting Treatment Adherence for Resilience and Thriving (START): A mHealth intervention to improve ART adherence for HIV-positive stimulant-using men$650,107
R01 · FY2020 · DA · contact PI
Enhancing Capacity for Mental Health Research and Care in Cambodia$618,916
R01 · FY2020 · MH
Adaptive intervention strategies to optimize PrEP clinical evaluation and uptake in stimulant-using men$231,198
R34 · FY2020 · DA · contact PI
University of Miami Developmental HIV/AIDS Mental Health Research Center (D-ARC)$177,257
P30 · FY2020 · MH · contact PI
Methamphetamine Use and HIV as Risk Factors for COVID-19$152,977
R01 · FY2020 · DA · contact PI
Supporting Treatment Adherence For Resilience and Thriving (START): A MHealth Intervention to Improve ART Adherence For HIV-Positive Stimulant Using Men - Diversity Supplement$64,930
R01 · FY2020 · DA · contact PI
MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence among HIV+ Prescription Opioid Users$62,448
R01 · FY2020 · DA
MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence among HIV+ Prescription Opioid Users$796,431
R01 · FY2019 · DA
Supporting Treatment Adherence for Resilience and Thriving (START): A mHealth intervention to improve ART adherence for HIV-positive stimulant-using men$718,290
R01 · FY2019 · DA · contact PI
Enhancing Capacity for Mental Health Research and Care in Cambodia$633,013
R01 · FY2019 · MH
Adaptive intervention strategies to optimize PrEP clinical evaluation and uptake in stimulant-using men$244,499
R34 · FY2019 · DA · contact PI
University of Miami Developmental HIV/AIDS Mental Health Research Center (D-ARC)$177,257
P30 · FY2019 · MH · contact PI
RCT of an integrative intervention for non-treatment-seeking meth users$536,149
R01 · FY2017 · DA
RCT of an integrative intervention for non-treatment-seeking meth users$564,601
R01 · FY2016 · DA
RCT of an integrative intervention for non-treatment-seeking meth users$9,046
R01 · FY2016 · DA · contact PI
RCT of an integrative intervention for non-treatment-seeking meth users$575,222
R01 · FY2015 · DA · contact PI
RCT of an integrative intervention for non-treatment-seeking meth users$542,055
R01 · FY2014 · DA · contact PI
RCT of an integrative intervention for non-treatment-seeking meth users$22,120
R01 · FY2014 · DA · contact PI
RCT of an integrative intervention for non-treatment-seeking meth users$560,081
R01 · FY2013 · DA · contact PI
RCT of an integrative intervention for non-treatment-seeking meth users$20,401
R01 · FY2013 · DA · contact PI
A Pilot RCT of Expressive Writing with HIV-Positive Methamphetamine Users$119,016
R03 · FY2011 · DA · contact PI
A Pilot RCT of Expressive Writing with HIV-Positive Methamphetamine Users$123,056
R03 · FY2010 · DA · contact PI
A Stress and Coping Model of Stimulant Use Among MSM$93,205
R03 · FY2010 · DA · contact PI